ATE467643T1 - Peptide mit proliferationshemmender wirkung - Google Patents
Peptide mit proliferationshemmender wirkungInfo
- Publication number
- ATE467643T1 ATE467643T1 AT07788860T AT07788860T ATE467643T1 AT E467643 T1 ATE467643 T1 AT E467643T1 AT 07788860 T AT07788860 T AT 07788860T AT 07788860 T AT07788860 T AT 07788860T AT E467643 T1 ATE467643 T1 AT E467643T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- proliferation effect
- seq
- proliferation
- effect
- Prior art date
Links
- 230000001028 anti-proliverative effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0605193A FR2902101B1 (fr) | 2006-06-12 | 2006-06-12 | Peptides a activite anti-proliferative |
| PCT/FR2007/000955 WO2007144492A2 (fr) | 2006-06-12 | 2007-06-11 | Peptides a activite anti-proliferative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE467643T1 true ATE467643T1 (de) | 2010-05-15 |
Family
ID=37546893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07788860T ATE467643T1 (de) | 2006-06-12 | 2007-06-11 | Peptide mit proliferationshemmender wirkung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7897578B2 (de) |
| EP (1) | EP2041173B1 (de) |
| JP (1) | JP5138680B2 (de) |
| AT (1) | ATE467643T1 (de) |
| CA (1) | CA2654956C (de) |
| DE (1) | DE602007006493D1 (de) |
| ES (1) | ES2342501T3 (de) |
| FR (1) | FR2902101B1 (de) |
| RU (1) | RU2446174C2 (de) |
| WO (1) | WO2007144492A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI523863B (zh) | 2012-11-01 | 2016-03-01 | 艾普森藥品公司 | 體抑素－多巴胺嵌合體類似物 |
| CN104768565B (zh) | 2012-11-01 | 2017-04-26 | 益普生制药股份有限公司 | 促生长素抑制素类似物及其二聚体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0942973B1 (de) * | 1996-11-28 | 2006-03-15 | Institut Gustave Roussy | Mutanten des lag-3 proteins, ihre expression und verwendung |
| EP0900841A1 (de) * | 1997-06-18 | 1999-03-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Spleissvarianten von LAG-3 |
| RU2267496C2 (ru) * | 2004-01-15 | 2006-01-10 | Сергей Иванович Черныш | Противоопухолевые и антивирусные пептиды |
| FR2868781B1 (fr) * | 2004-04-13 | 2008-02-22 | Immutep | Composition de vaccin comprenant un ligand cmh de classe ii couple a un antigene, procede de preparation et utilisations |
-
2006
- 2006-06-12 FR FR0605193A patent/FR2902101B1/fr active Active
-
2007
- 2007-06-11 RU RU2008152813/10A patent/RU2446174C2/ru not_active IP Right Cessation
- 2007-06-11 EP EP07788860A patent/EP2041173B1/de not_active Not-in-force
- 2007-06-11 WO PCT/FR2007/000955 patent/WO2007144492A2/fr not_active Ceased
- 2007-06-11 DE DE602007006493T patent/DE602007006493D1/de active Active
- 2007-06-11 CA CA2654956A patent/CA2654956C/fr not_active Expired - Fee Related
- 2007-06-11 AT AT07788860T patent/ATE467643T1/de not_active IP Right Cessation
- 2007-06-11 JP JP2009514841A patent/JP5138680B2/ja not_active Expired - Fee Related
- 2007-06-11 ES ES07788860T patent/ES2342501T3/es active Active
- 2007-06-11 US US12/304,746 patent/US7897578B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2041173B1 (de) | 2010-05-12 |
| JP5138680B2 (ja) | 2013-02-06 |
| US20090209466A1 (en) | 2009-08-20 |
| RU2446174C2 (ru) | 2012-03-27 |
| CA2654956C (fr) | 2016-11-01 |
| WO2007144492A2 (fr) | 2007-12-21 |
| JP2009539947A (ja) | 2009-11-19 |
| WO2007144492A3 (fr) | 2008-01-24 |
| FR2902101B1 (fr) | 2012-12-28 |
| FR2902101A1 (fr) | 2007-12-14 |
| DE602007006493D1 (de) | 2010-06-24 |
| US7897578B2 (en) | 2011-03-01 |
| RU2008152813A (ru) | 2010-07-20 |
| CA2654956A1 (fr) | 2007-12-21 |
| ES2342501T3 (es) | 2010-07-07 |
| EP2041173A2 (de) | 2009-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA118167C2 (uk) | Пептид та його застосування | |
| EA201170878A1 (ru) | Полипептиды с ксиланазной активностью | |
| NZ600690A (en) | Fkbp-l and uses thereof | |
| EA201000327A1 (ru) | Белок | |
| EA201300455A1 (ru) | Полипептиды с пермеазной активностью | |
| NZ596658A (en) | Dig-10 insecticidal cry toxins | |
| IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
| SI2190473T1 (sl) | Peptid z zmanjšano tvorbo dimerov | |
| ES2385093T3 (es) | Análogos de oxintomodulina y sus efectos sobre el comportamiento de la conducta alimentaria | |
| NZ607069A (en) | Modified relaxin polypeptides and their uses | |
| DE602005008996D1 (de) | Radiofluorierte peptide | |
| ES2530670T3 (es) | Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo | |
| NZ609216A (en) | Anticancer fusion protein | |
| CY1116269T1 (el) | Χρηση μιας πρωτεϊνης απο λουπινο | |
| CO6430475A2 (es) | Polipéptidos que tienen actividad de celulasa | |
| WO2008093058A3 (en) | Peptides and their use | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| RU2022100555A (ru) | Новый пептид | |
| CY1111630T1 (el) | Παραγωγα κυτοκινων | |
| TR201902131T4 (tr) | Enfeksiyöz bronşit virüsünün (IBV) doku tropizmini uzatan mutant diken proteini. | |
| ITRM20040349A1 (it) | Peptidi antibatterici e loro analoghi. | |
| DE602007001519D1 (de) | Zusammensetzung mit mehreren botulinumtoxinen | |
| NZ601647A (en) | Variant hhip1 protein and methods and uses thereof | |
| DE50213015D1 (de) | Lipase-varianten | |
| ATE467643T1 (de) | Peptide mit proliferationshemmender wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |